Promotional price valid on web orders only. Your contract pricing may differ. Interested in signing up for a dedicated account number?
Learn More
  1. Home
  2. Products
  3. 5000358165

Medchemexpress LLC Elacridar | 143664-11-3 | 99.7% | C34H33N3O5 | 1 G
SDP

Catalog No. 5000358165
Encompass_Preferred

Elacridar is an orally active P-glycoprotein (Pgp) and breast cancer resistance protein (BCRP) inhibitor. It is utilized to investigate the impact of efflux transporters on agent distribution to the brain and for cancer research.

  • Orally active P-glycoprotein (Pgp) and breast cancer resistance protein (BCRP) inhibitor
  • Used to examine the influence of efflux transporters on agent distribution to the brain
  • Useful in cancer research applications
  • Inhibits cell viability in 786-O cells
  • Affects P-glycoprotein and ABCG2 protein expression levels in MCF-7 and 786-O cell lines
  • Increases 99mTc-MIBI intracellular accumulation in MCF-7 and 786-O cells

Catalog No. 50-003-58165 Supplier Medchemexpress LLC Supplier No. HY508791G
May include imposed supplier surcharges.
Add to Cart
Add to Cart

missing translation for 'validMainframeMsg'

Elacridar is an orally active P-glycoprotein (Pgp) and breast cancer resistance protein (BCRP) inhibitor. It is utilized to investigate the impact of efflux transporters on agent distribution to the brain and for cancer research.

  • Orally active P-glycoprotein (Pgp) and breast cancer resistance protein (BCRP) inhibitor
  • Used to examine the influence of efflux transporters on agent distribution to the brain
  • Useful in cancer research applications
  • Inhibits cell viability in 786-O cells
  • Affects P-glycoprotein and ABCG2 protein expression levels in MCF-7 and 786-O cell lines
  • Increases 99mTc-MIBI intracellular accumulation in MCF-7 and 786-O cells

Product Title
Select an issue

By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.